AIRLINK 195.01 Increased By ▲ 1.24 (0.64%)
BOP 9.77 Decreased By ▼ -0.10 (-1.01%)
CNERGY 7.36 Decreased By ▼ -0.21 (-2.77%)
FCCL 38.77 Decreased By ▼ -0.64 (-1.62%)
FFL 15.59 Decreased By ▼ -0.70 (-4.3%)
FLYNG 25.41 Decreased By ▼ -0.43 (-1.66%)
HUBC 128.62 Decreased By ▼ -1.24 (-0.95%)
HUMNL 13.81 Decreased By ▼ -0.02 (-0.14%)
KEL 4.49 Decreased By ▼ -0.04 (-0.88%)
KOSM 6.30 Decreased By ▼ -0.17 (-2.63%)
MLCF 44.79 Decreased By ▼ -0.78 (-1.71%)
OGDC 203.60 Decreased By ▼ -5.51 (-2.63%)
PACE 6.42 Decreased By ▼ -0.30 (-4.46%)
PAEL 41.13 Decreased By ▼ -0.72 (-1.72%)
PIAHCLA 16.72 Decreased By ▼ -0.41 (-2.39%)
PIBTL 7.68 Decreased By ▼ -0.22 (-2.78%)
POWER 9.04 Decreased By ▼ -0.32 (-3.42%)
PPL 173.91 Decreased By ▼ -4.01 (-2.25%)
PRL 39.08 Increased By ▲ 0.07 (0.18%)
PTC 25.04 Decreased By ▼ -0.49 (-1.92%)
SEARL 109.06 Increased By ▲ 2.33 (2.18%)
SILK 0.99 No Change ▼ 0.00 (0%)
SSGC 38.14 Decreased By ▼ -1.39 (-3.52%)
SYM 19.49 Increased By ▲ 0.04 (0.21%)
TELE 8.36 Decreased By ▼ -0.28 (-3.24%)
TPLP 12.13 Decreased By ▼ -0.40 (-3.19%)
TRG 64.79 Decreased By ▼ -0.55 (-0.84%)
WAVESAPP 10.57 Decreased By ▼ -0.58 (-5.2%)
WTL 1.69 Decreased By ▼ -0.04 (-2.31%)
YOUW 3.87 Decreased By ▼ -0.07 (-1.78%)
BR100 11,888 Decreased By -141.9 (-1.18%)
BR30 35,219 Decreased By -592.9 (-1.66%)
KSE100 112,030 Decreased By -1490 (-1.31%)
KSE30 35,136 Decreased By -515.4 (-1.45%)

Moderna vaccines

Moderna testing new COVID-19 vaccine as potential booster shot
Business & Finance

Moderna testing new COVID-19 vaccine as potential booster shot

  • The early-stage study will assess the safety and immunogenicity of mRNA-1283 at three dose levels, and will be given to healthy adults either as a single dose or in two doses 28 days apart, the company said.
  • Last week, Moderna began dosing the first participants in a study testing its COVID-19 booster vaccine candidates.
Updated 15 Mar, 2021 09:25pm
EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine
Business & Finance

EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

  • The COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech , AstraZeneca-Oxford University and Moderna, and is recommended for those over 18 years of age.
  • With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens.
Published 11 Mar, 2021 06:48pm